Clinical trials: Premature Ejaculation
Premature Ejaculation
Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation
Prospective, non-randomized, controlled, single-center study, to evaluate the efficacy of applied nominal electrical stimulation parameters given to premature ejaculation (PE) patients in order to prolong the ejaculatory latency…
- Trial name
- NCT03177226
- Testing
- Functional TENS stimulation, Non-Functional TENS stimulation
- Where
- Israel
- Volunteers
- 30 people
- Sponsor
- Virility Medical Ltd.
Premature Ejaculation
PSD502 in Subjects With Premature Ejaculation
This study is being done to test the effect of PSD502 (the study medication) compared to placebo in subjects with premature ejaculation.
- Trial name
- NCT03578783
- Testing
- PSD502
- Where
- 21 sites in United States
- Volunteers
- 121 people
- Sponsor
- Plethora Solutions Ltd
Ejaculation
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
The primary purpose of the study is to demonstrate that dapoxetine can prolong intravaginal ejaculatory latency time (IELT) compared with placebo in men with premature ejaculation (PE).
- Trial name
- NCT00211094
- Testing
- Dapoxetine
- Volunteers
- 1,320 people
- Sponsor
- Alza Corporation, DE, USA
Ejaculation
Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation
Assessment of efficacy and safety UK-390,957.
- Trial name
- NCT00219583
- Testing
- UK-390,957
- Where
- 49 sites in Australia, Austria and 12 more
- Volunteers
- 460 people
- Sponsor
- Pfizer
Premature Ejaculation
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
The purpose of this study is to determine the effectiveness of IX-01 in men with lifelong premature ejaculation.
- Trial name
- NCT02232425
- Testing
- IX-01
- Where
- 10 sites in United States, Australia
- Volunteers
- 88 people
- Sponsor
- Ixchelsis Limited
Sexual Dysfunction, Ejaculation
A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation
The primary purpose of the study is to assess the possible withdrawal effects after abruptly stopping daily therapy with dapoxetine compared with continuing daily therapy in men with premature ejaculation (PE).
- Trial name
- NCT00210613
- Testing
- Dapoxetine
- Volunteers
- 199 people
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Premature Ejaculation
Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation
Objective: Evaluate the effectiveness and safety of transcutaneous electrostimulation of the posterior tibial nerve alone and combined with standard pharmacological treatment, in men with primary premature ejaculation, compared…
- Trial name
- NCT04207723
- Testing
- Transcutaneous posterior tibial nerve stimulation, Paroxetine
- Where
- Colombia
- Volunteers
- 120 people
- Sponsor
- Boston Medical Group
Premature Ejaculation
A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation
A phase I, single-center, double-blind, randomized, placebo-controlled, safety and pharmacokinetic study to evaluate systemic and local vaginal exposure to lidocaine and prilocaine and the metabolites, 2,6-dimethylaniline…
- Trial name
- NCT01184105
- Testing
- Intervention A, Intervention B
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Plethora Solutions Ltd
Erectile Dysfunction, Premature (Early) Ejaculation
Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.
The objective of this clinical trial is to evaluate the effectiveness of pelvic floor therapy for the management of erectile dysfunction and premature ejaculation in patients with erectile dysfunction and premature ejaculation.
- Conditions
- Erectile Dysfunction, Premature (Early) Ejaculation, Premature Ejaculation, Pelvic Floor; Weak
- Trial name
- NCT06425211
- Testing
- Therapeutic exercises, Perineal electromyographic biofeedback, Electrical stimulation
- Where
- Colombia
- Volunteers
- 66 people
- Sponsor
- Boston Medical Group
Premature Ejaculation
Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation
As study to investigate the efficacy and safety of daily doses of paroxetine of 15 and 20 mg for the treatment of premature ejaculation
- Trial name
- NCT01024491
- Testing
- paroxetine
- Where
- 2 sites in Mexico
- Volunteers
- 174 people
- Sponsor
- MorePharma Corporation
Ejaculation
A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin
The purpose of this study is to assess the pharmacodynamics (the actions or effects a drug has on the body), pharmacokinetics (blood levels), safety, and tolerability of dapoxetine 60 mg when concomitantly administered in…
- Trial name
- NCT01366664
- Testing
- Treatment sequence 2, Treatment sequence 1
- Where
- 6 sites in United States
- Volunteers
- 24 people
- Sponsor
- Janssen Research & Development, LLC
Sexual Dysfunction, Physiological
PRILIGY Usage Patterns in Selected Populations
This study will use electronic health services databases to describe the usage patterns of dapoxetine hydrochloride (PRILIGY) in Germany and Italy with a focus on describing the extent and proportion of patients with…
- Trial name
- NCT01273545
- Testing
- PRILIGY (dapoxetine hydrochloride)
- Volunteers
- 3,000 people
- Sponsor
- Janssen Research & Development, LLC
Premature Ejaculation, Erectile Dysfunction
The Safety of Dapoxetine/Tadalafil Combination Therapy
The purpose of this study is to evaluate the safety and efficacy of Dapoxetine/Tadalafil 30/20 mg film-coated tablet in the treatment of men with premature ejaculation and erectile dysfunction.
- Conditions
- Premature Ejaculation, Erectile Dysfunction, Safety Issues
- Trial name
- NCT03177746
- Testing
- Dapoxetine/Tadalafil 30/20 mg film coated tablet
- Where
- Turkey (Türkiye)
- Volunteers
- 40 people
- Sponsor
- Neutec Ar-Ge San ve Tic A.Ş
Obstetric Labour, Premature, Premature Ejaculation
A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects
PreTerm Labor (prior to 37 weeks gestation) is the largest single cause of infant morbidity and mortality and is frequently associated with long-term disability. Oxytocin is a hormone produced by the body during labor.
- Trial name
- NCT00449709
- Testing
- GSK221149
- Where
- United States
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- GlaxoSmithKline
Ejaculation
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.
The primary purpose of the study is to demonstrate that dapoxetine can prolong intravaginal ejaculatory latency time (IELT) compared with placebo in men with premature ejaculation (PE).
- Trial name
- NCT00211107
- Testing
- Dapoxetine
- Volunteers
- 1,294 people
- Sponsor
- Alza Corporation, DE, USA